Program Schedule

New Discoveries on Classical Group A Streptococcal Antigens and Their Virulence Functions

Session: Symposium: Update on Flesh Eating Bacteria: New Insights into Group A Streptococci from Vaccine Development to Molecular Pathogenesis
Saturday, October 11, 2014: 2:30 PM
Room: The Pennsylvania Convention Center: 114
Victor Nizet, MD, Pediatrics & Pharmacy, University of California San Diego, La Jolla, CA

Victor Nizet is a Professor of Pediatrics and Pharmacy at the University of California, San Diego and Chief of the Division of Pediatric Pharmacology & Drug Discovery at University of California San Diego (UCSD) School of Medicine and Skaggs School of Pharmacy & Pharmaceutical Sciences. Dr. Nizet received his medical training at Stanford University School of Medicine, completed a Residency and Chief Residency in Pediatrics at Harvard University's Children's Hospital in Boston, Massachusetts, and a Fellowship in Pediatric Infectious Diseases at the University of Washington's Children's Hospital in Seattle. Dr. Nizet leads a large basic and translational research laboratory focused on discovering virulence factors of Gram-positive bacterial pathogens, elucidating mechanisms of host innate immunity, and novel approaches to infectious disease therapy. He is also currently leading the initiative for a UCSD Health Sciences Center for Immunity, Infection & Inflammation which will debut in 2014. Dr. Nizet has authored over 290 peer-reviewed publications (> 100 since 2011), including several in the most prestigious general scientific journals. He has collaborated with several biotechnology interests in developing new antibiotic and immune-based therapies against drug-resistant pathogens. Dr. Nizet's work has been recognized by an American Heart Association Established Investigator Award, the American Lung Association Career Investigator Award, the American Asthma Foundation Senior Investigator Award, and the E. Mead Johnson Award for Research in Pediatrics. Dr. Nizet has been elected to the American Society for Clinical Investigation, the Association of American Physicians, and the American Academy of Microbiology. Details of his research program can be found on the laboratory website:

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek